Announcement of GUDID Release 2.2 Deployment and Document Updates

By AHRMM

GUDID Release 2.2 was successfully deployed. The enhancements will allow for additional functionality as noted below.

  • Labelers will be able to “unlock” their device records after the DI record grace period to make error corrections. This will eliminate the need to contact the FDA UDI Help Desk to make corrections after the grace period.

Note that the Unlock functionality is intended to be used to correct data submission errors after the grace period. DO NOT USE Unlock functionality for edits that require assignment of a NEW Device Identifier. Please assign a new Device Identifier and submit a new record if you are changing data elements that are “New DI Triggers” (i.e., not correcting submission errors)

  • Addition of new data elements to the GUDID download file made available on AccessGUDID and OpenFDA to include –
  • Public Version Number
  • Public Version Date
  • Public Version Status (new/update/delete)
  • Public Device Record Key
  • Labeler DUNS Number
  • Premarket Submission Number & Supplement Number – note that this will be released after the testing/review period as indicated here.

GUDID documents (listed below) have been updated as of March 30, 2018.

We have also updated the GUDID System Enhancements and Fixes page to reflect all releases to-date.

If you have questions, concerns or feedback, please contact the FDA UDI Help Desk.

 

Related Resources

Toolkits/Methodology
The Unique Device Identifier (UDI) is comprised of 2 segments:
Webcast
Karen Conway, Vice President, Healthcare Value at GHX and Mike Schiller, Senior Director of Supply Chain at AHRMM discuss the value of UDI beyond r
Podcasts
Hear one provider’s ongoing process of UDI implementation, from deciphering acronyms and educating interdepartmental staff, to working with vendors
Webcast
Supply chain is in the unique position, working with so many different disciplines within the hospital, that it is natural that they initiate conve
Podcasts
AHRMM Podcast on how supply chain should be interdepartmentally conversing to determine the handling of human-origin medical products and their UDIs.